These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 25636756

  • 1. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A, Wong J, Kleinerman R, Kim C, Morton L, Bekelman JE.
    Int J Radiat Oncol Biol Phys; 2015 Feb 01; 91(2):295-302. PubMed ID: 25636756
    [Abstract] [Full Text] [Related]

  • 2. [Second neoplasms after percutaneous radiotherapy].
    Haidl F, Pfister D, Semrau R, Heidenreich A.
    Urologe A; 2017 Mar 01; 56(3):342-350. PubMed ID: 27844130
    [Abstract] [Full Text] [Related]

  • 3. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):669-73. PubMed ID: 16887293
    [Abstract] [Full Text] [Related]

  • 4. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM, Porter MP, Soloway MS.
    J Urol; 2008 Nov 01; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [Abstract] [Full Text] [Related]

  • 5. Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy.
    Tward JD, Jarosek S, Chu H, Thorpe C, Shrieve DC, Elliott S.
    Int J Radiat Oncol Biol Phys; 2016 Aug 01; 95(5):1443-1453. PubMed ID: 27325475
    [Abstract] [Full Text] [Related]

  • 6. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
    Huo D, Hetzel JT, Roy H, Rubin DT.
    Cancer Epidemiol Biomarkers Prev; 2009 Jul 01; 18(7):1979-85. PubMed ID: 19531678
    [Abstract] [Full Text] [Related]

  • 7. Cancer incidence after localized therapy for prostate cancer.
    Moon K, Stukenborg GJ, Keim J, Theodorescu D.
    Cancer; 2006 Sep 01; 107(5):991-8. PubMed ID: 16878323
    [Abstract] [Full Text] [Related]

  • 8. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
    Abdel-Wahab M, Reis IM, Hamilton K.
    Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):58-68. PubMed ID: 18374503
    [Abstract] [Full Text] [Related]

  • 9. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE, Rodríguez D, Nagle RT, Mossanen M, Kibel AS, Chang SL.
    Urol Oncol; 2018 Nov 01; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [Abstract] [Full Text] [Related]

  • 10. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD, Dores GM, Gilbert ES.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1354-65. PubMed ID: 16174857
    [Abstract] [Full Text] [Related]

  • 11. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
    Murray L, Mason J, Henry AM, Hoskin P, Siebert FA, Venselaar J, Bownes P, UroGEC/BRAPHYQS group of the GEC ESTRO.
    Radiother Oncol; 2016 Aug 21; 120(2):293-9. PubMed ID: 27370205
    [Abstract] [Full Text] [Related]

  • 12. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, Soria F, Mattei A, Montorsi F, Briganti A, Shariat SF.
    Eur Urol; 2019 Feb 21; 75(2):319-328. PubMed ID: 30293908
    [Abstract] [Full Text] [Related]

  • 13. Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer.
    Zelefsky MJ, Housman DM, Pei X, Alicikus Z, Magsanoc JM, Dauer LT, St Germain J, Yamada Y, Kollmeier M, Cox B, Zhang Z.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):953-9. PubMed ID: 22172904
    [Abstract] [Full Text] [Related]

  • 14. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
    Hamilton SN, Tyldesley S, Hamm J, Jiang WN, Keyes M, Pickles T, Lapointe V, Kahnamelli A, McKenzie M, Miller S, Morris WJ.
    Int J Radiat Oncol Biol Phys; 2014 Nov 15; 90(4):934-41. PubMed ID: 25240272
    [Abstract] [Full Text] [Related]

  • 15. Secondary Cancers After Radiation Therapy for Primary Prostate or Rectal Cancer.
    Lee YC, Hsieh CC, Li CY, Chuang JP, Lee JC.
    World J Surg; 2016 Apr 15; 40(4):895-905. PubMed ID: 26711638
    [Abstract] [Full Text] [Related]

  • 16. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
    Pithadia KJ, Advani PG, Citrin DE, Bekelman JE, Withrow DR, Berrington de Gonzalez A, Morton LM, Schonfeld SJ.
    JAMA Oncol; 2023 Aug 01; 9(8):1119-1123. PubMed ID: 37289449
    [Abstract] [Full Text] [Related]

  • 17. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
    Turcotte LM, Liu Q, Yasui Y, Arnold MA, Hammond S, Howell RM, Smith SA, Weathers RE, Henderson TO, Gibson TM, Leisenring W, Armstrong GT, Robison LL, Neglia JP.
    JAMA; 2017 Feb 28; 317(8):814-824. PubMed ID: 28245323
    [Abstract] [Full Text] [Related]

  • 18. Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer.
    Stokkevåg CH, Engeseth GM, Hysing LB, Ytre-Hauge KS, Ekanger C, Muren LP.
    Acta Oncol; 2015 Feb 28; 54(9):1317-25. PubMed ID: 26230629
    [Abstract] [Full Text] [Related]

  • 19. Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.
    Musunuru H, Mason M, Murray L, Al-Qaisieh B, Bownes P, Smith J, Franks K, Carey B, Bottomley D, Henry AM.
    Clin Oncol (R Coll Radiol); 2014 Apr 28; 26(4):210-5. PubMed ID: 24507938
    [Abstract] [Full Text] [Related]

  • 20. The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement.
    Cheung AK, Chen MH, Moran BJ, Braccioforte MH, Dosoretz DE, Salenius S, Katin M, Ross R, D'Amico AV.
    Brachytherapy; 2010 Apr 28; 9(2):145-50. PubMed ID: 20346894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.